Clinical Trial: LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07325539) titled 'LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC' on Dec. 24, 2025.

Brief Summary: This study aims to evaluate the efficacy and safety of LDRT combined with toripalimab and GP chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma through a prospective, open-label, single-arm Phase II clinical trial.

Study Start Date: Jan. 01

Study Type: INTERVENTIONAL

Condition: Nasopharyngeal Cancinoma (NPC) Nasopharangeal Cancer

Intervention: DRUG: Gemcitabine(GEM)

Gemcitabine 1000mg/m2, d1 & 8 of every cycle, every 3 weeks for 4-6 cycles

DRUG: Cisplatin

Cisplatin 80mg/m2, d1 of every cy...